Deutsche Tageszeitung - PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference


PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level).

Change text size:

About PromiCell, Inc.

PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 TCR T cells and CD 33 CAR T cells, applicable for the treatment of patients with mCRPC, Ewing Sarcoma, recurrent leukemia and acute myeloid leukemia. Our next-generation chimeric antigen receptor CAR T cell therapies are designed to address key mechanisms of tumor escape, disease relapse, and immune evasion. Our scientists are pioneers in CAR T-cell therapy, united in a mission to outsmart cancer and deliver more cures for patients. Learn more at www.promicell.com.

Contact:

305-433-1287
[email protected]

SOURCE: Promicell



View the original press release on ACCESS Newswire

(T.W.Lukyanenko--DTZ)

Featured

US Government Questions Effectiveness of Waymo’s School Bus Software Fix

The US National Highway Traffic Safety Administration is examining whether a software update issued by Waymo effectively resolved safety issues involving its autonomous vehicles improperly passing stopped school buses. Federal regulators found that the majority of such incidents occurred after the company claimed to have fixed the problem, prompting a formal inquiry into the recall's efficacy.

Sweet As app launches restaurant discovery platform

Tired of Google and Instagram serving the same predictable restaurant recommendations? Or waiting on friends to finally text back with a suggestion?

Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent

Jensen Huang, CEO of tech giant Nvidia, has publicly admitted to an affair with a suspected Chinese spy. The company is one of the most valuable in the world and is at the centre of China's AI race, producing the most advanced AI chips ever seen.

Nvidia CEO Jensen Huang Admits Infidelity Amid Spy Investigation

Nvidia chief executive Jensen Huang has publicly admitted to having a romantic relationship with an alleged Chinese intelligence agent, issuing a personal apology to his family as the company’s board of directors initiates an independent investigation into the matter. The admission follows intense scrutiny from US lawmakers regarding Huang's interactions and Nvidia's lobbying efforts for relaxed chip export policies to China.

Change text size: